Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

No link found between aromatase gene and female hair loss.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Intense pulsed light treatment mainly damages pigmented hair parts but spares stem cells, allowing hair to regrow.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Wearing a wig caused a skin condition to develop in a woman with hair loss.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Hair follicles prevent NK cell attacks to avoid hair loss.

A reliable system was developed to distinguish hair growth stages, aiding in identifying hair growth promoters or inhibitors.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Hair follicles could help develop eye treatments by studying immune responses.

High mTORC1 activity slows hair growth and causes it to lose color.

Caffeine may help reduce stress-induced hair loss.

Human skin can be reconnected to nerves using stem cells, which may help with skin health and healing.

The GNP crosslinked scaffold with antibacterial coating is effective for rapid wound healing and infection prevention.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Interleukin-15 can help hair growth and protect hair follicles.